Search research articles
Contact Us
Filters
Showing results (951-960 of 965) with videos related to
Page
of 97
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
December 22, 2009
The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors
Kristin E Rosner, Zhuyan Guo, Peter Orth, et al.
Blood
|
August 27, 2025
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia
Mark B Geyer, Susan DeWolf, Xiaoli Mi, et al.
Blood Advances
|
March 1, 2023
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL
Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, et al.
JAMA Oncology
|
September 28, 2023
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial
Stuart J Wong, Pedro A Torres-Saavedra, Nabil F Saba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2021
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report
Liora M Schultz, Christina Baggott, Snehit Prabhu, et al.
Neuro-Oncology
|
July 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial
Andrew B Lassman, Stephanie L Pugh, Tony J C Wang, et al.
Blood Advances
|
August 19, 2025
International Consensus Guidelines for the Conduct and Reporting of CAR T-Cell Clinical Trials in AML
Swati Naik, Richard Aplenc, Susanne H C Baumeister, et al.
Blood
|
April 21, 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
Kai Rejeski, Jaime Sanz, Teng Fei, et al.
Blood Advances
|
July 21, 2025
Characterization and prediction of hematotoxicity in pediatric patients receiving tisagenlecuecel
Swati Naik, Subodh Selukar, Aimee C Talleur, et al.
Frontiers in Immunology
|
November 15, 2023
Mediport use as an acceptable standard for CAR T cell infusion
Maya Eylon, Snehit Prabhu, Samuel John, et al.
Page
of 97
Search research articles
Search
Showing results (951-960 of 965) with videos related to
Sort By:
Page
of 97
Bioorganic & Medicinal Chemistry Letters
|
December 22, 2009
The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors
Kristin E Rosner, Zhuyan Guo, Peter Orth, et al.
Blood
|
August 27, 2025
CD371-Targeted CAR T cells Secreting Interleukin-18 Exhibit Robust Expansion and Clear Refractory Acute Myeloid Leukemia
Mark B Geyer, Susan DeWolf, Xiaoli Mi, et al.
Blood Advances
|
March 1, 2023
HLH-like toxicities predict poor survival after the use of tisagenlecleucel in children and young adults with B-ALL
Kevin O McNerney, Stephanie J Si Lim, Kyle Ishikawa, et al.
JAMA Oncology
|
September 28, 2023
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial
Stuart J Wong, Pedro A Torres-Saavedra, Nabil F Saba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 9, 2021
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report
Liora M Schultz, Christina Baggott, Snehit Prabhu, et al.
Neuro-Oncology
|
July 18, 2022
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial
Andrew B Lassman, Stephanie L Pugh, Tony J C Wang, et al.
Blood Advances
|
August 19, 2025
International Consensus Guidelines for the Conduct and Reporting of CAR T-Cell Clinical Trials in AML
Swati Naik, Richard Aplenc, Susanne H C Baumeister, et al.
Blood
|
April 21, 2025
T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy
Kai Rejeski, Jaime Sanz, Teng Fei, et al.
Blood Advances
|
July 21, 2025
Characterization and prediction of hematotoxicity in pediatric patients receiving tisagenlecuecel
Swati Naik, Subodh Selukar, Aimee C Talleur, et al.
Frontiers in Immunology
|
November 15, 2023
Mediport use as an acceptable standard for CAR T cell infusion
Maya Eylon, Snehit Prabhu, Samuel John, et al.
Page
of 97